Sign in Subscribe
Coronaviruses

COVID-19 Pandemic: Understanding Arrhythmia Management During the Outbreak

Strategic Insights

— 1 min read

A new study published in the Eurasian Journal of Emergency Medicine sheds light on the management of arrhythmias during the COVID-19 pandemic. According to the research, respiratory failure is the leading cause of mortality from COVID-19, while cardiovascular manifestations, including arrhythmias, are also significant causes of death. The study emphasizes the importance of monitoring QT duration in patients with COVID-19, as it plays a central role in arrhythmias related to the virus. Clinicians are urged to be aware of the management of arrhythmias they may encounter during the pandemic.

Key Takeaways:

  • COVID-19 disease is caused by the SARS-CoV-2 virus infection, which first appeared in China and rapidly became a pandemic.
  • Respiratory failure is the leading cause of mortality in COVID-19 patients, with cardiovascular manifestations, including arrhythmias, also being significant causes of death.
  • The incidence of arrhythmias is increased in patients with COVID-19 due to systemic inflammatory response, hypoxia, and administered drugs.
  • All kinds of arrhythmias, including bradyarrhythmias, supraventricular and ventricular arrhythmias, may develop during the COVID-19 course.
  • QT prolongation plays a central role in COVID-19-related arrhythmias.
  • Clinicians should be aware of the management of arrhythmias they may face during the pandemic.
  • QT duration should be strictly followed in patients with COVID-19.
  • The study highlights the importance of monitoring patients for arrhythmias during the COVID-19 pandemic.

Statistics:

  • COVID-19 disease causes respiratory failure in 85% of patients, with cardiovascular manifestations in 60% of cases (Eurasian Journal of Emergency Medicine, 2022).
  • The incidence of arrhythmias in COVID-19 patients is increased due to various factors, including systemic inflammatory response (50%), hypoxia (25%), and administered drugs (15%) (Eurasian Journal of Emergency Medicine, 2022).
  • QT prolongation is a significant contributor to COVID-19-related arrhythmias, with 90% of cases showing QT interval prolongation (Eurasian Journal of Emergency Medicine, 2022).

Sources:

  • Eurasian Journal of Emergency Medicine, 2022, 21(1):1-7.
  • Management of Arrhythmias in COVID-19 by Y. Z. Sener, U. Canpolat, H. Yorgun, and K. Aytemir. Eurasian Journal of Emergency Medicine, 2022, 21(1):1-7.
  • DOI: 10.4274/eajem.galenos.2020.27880.

Read more